Sugi Predict

Sugi Predict / Compounds / SCHEMBL1673194

SCHEMBL1673194

SCHEMBL1673194

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)[C@@H](C)O

nearest known ligand 0.58

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SLC6A5 Q9Y345 1/20 0.58
▸ NMT1 P30419 6/20 0.58
▸ NMT2 O60551 5/20 0.58
▸ TLR2 O60603 2/20 0.55
▸ CTSL P07711 1/20 0.52
▸ NOD1 Q9Y239 4/20 0.50
▸ FAAH O00519 1/20 0.46
▸ ITGB3 P05106 1/20 0.45
▸ ITGA2B P08514 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1280087 1.00 SLC6A5 (0.58) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL1673186 1.00 SLC6A5 (0.58) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL352420 1.00 SLC6A5 (0.58) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL30905802 1.00 SLC6A5 (0.58) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL30399641 1.00 SLC6A5 (0.58) SLC6A5NMT1NMT2TLR2CTSL
Acetic Acid SCHEMBL29600169 0.98 SLC6A5 (0.56) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL23227556 0.97 CTSL (0.56) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL31307622 0.97 SLC6A5 (0.54) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL31307690 0.97 SLC6A5 (0.54) SLC6A5NMT1NMT2TLR2CTSL
SCHEMBL31307638 0.97 SLC6A5 (0.54) SLC6A5NMT1NMT2TLR2CTSL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113749963-B Polypeptide composition for promoting skin microcirculation and application thereof 无限极（中国）有限公司 2024-04-02 — — CN disclosed
EP-3253400-B1 OLEANOYL PEPTIDE COMPOSITION MAJEED MUHAMMED (US) 2023-01-18 — — EP disclosed
CN-110051626-B Two-phase oil preparation and application thereof 杜权 2022-10-04 — — CN disclosed
US-20220281919-A1 pH-SENSITIVE CYCLIC PEPTIDES UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES 2022-09-08 — — US disclosed
CN-114929191-A Skin care formulations with lipophilins 德西姆美容集团公司 2022-08-19 — — CN disclosed
CN-114555045-A Peptide-based cosmetic or dermatological treatment of skin and its appendages 赛德玛公司 2022-05-27 — — CN disclosed
US-11274126-B2 pH-sensitive cyclic peptides UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES (US) 2022-03-15 — — US disclosed
CN-113081888-A Polypeptide repairing extracting solution and preparation method thereof 榆林市恒丽贸易有限公司 2021-07-09 — — CN disclosed
CN-111840176-A A skin caring composition with effects of resisting glycosylation, whitening skin, removing speckle and removing wrinkle, and its application 上海海璐希实业有限公司 2020-10-30 — — CN disclosed
EP-3432908-A1 pH-SENSITIVE PEPTIDES Rhode Island Council on Postsecondary Education (US) 2019-01-30 — — EP disclosed
WO-2012091743-A1 OLEANOYL PEPTIDE COMPOSITION AND A METHOD OF TREATING SKIN AGING SAMI LABS LIMITED (IN) 2012-07-05 — — WO disclosed
US-8025907-B2 Cosmetic composition to accelerate repair of functional wrinkles BELFER COSMETICS LLC 2011-09-27 — — US disclosed
US-20110091398-A1 OLEANOYL PEPTIDE COMPOSITION AND A METHOD OF TREATING SKIN AGING SAMI LABS LTD (IN) 2011-04-21 — — US disclosed
WO-2010050980-A1 TOPICAL FORMULATIONS COMPRISING HYDROXYAPATITE PARTICLES FOR STIMULATION AND MAINTENANCE OF COLLAGEN FIBERS LABORATORY SKIN CARE, INC. (US) 2010-05-06 — — WO disclosed
US-20100034758-A1 Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals SAMI LABS LIMITED (IN) 2010-02-11 — — US disclosed
US-20090280078-A1 Cosmetic composition to accelerate repair of functional wrinkles BELFER COSMETICS LLC 2009-11-12 — — US disclosed
US-7566464-B2 Cosmetic composition to accelerate repair of functional wrinkles BELFER COSMETICS, LLC 2009-07-28 — — US disclosed
US-20090169651-A1 ANTI-SKIN DAMAGE COMPOSITIONS WITH COMPLIMENTARY DUAL MODE OF ACTION SAMI LABS LIMITED (IN) 2009-07-02 — — US disclosed
WO-2008020954-A2 COSMETIC COMPOSITION TO ACCELERATE REPAIR OF FUNCTIONAL WRINKLES BELFER WILLIAM A (US) 2008-02-21 — — WO disclosed
US-20070048245-A1 Cosmetic composition to accelerate repair of functional wrinkles BELFER COSMETICS, LLC 2007-03-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274126-B2 pH-sensitive cyclic peptides VIP, PHLPP1, PHLPP2 SLC6A5 1927/4885NMT1 1269/4885NMT2 1219/4885
US-20220281919-A1 pH-SENSITIVE CYCLIC PEPTIDES VIP, PHLPP1, PHLPP2 SLC6A5 1927/4885NMT1 1269/4885NMT2 1219/4885
US-20110091398-A1 OLEANOYL PEPTIDE COMPOSITION AND A METHOD OF TREATING SKIN AGING MMP1, MMP13, MMP11 SLC6A5 4856/4885NMT1 2717/4885NMT2 3302/4885
US-20100034758-A1 Peptides Modified with Triterpenoids and Small Organic Molecules: Synthesis and use in Cosmeceuticals CUTA, MMP1, MMP13 SLC6A5 4874/4885NMT1 3334/4885NMT2 3527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.